Goldman Sachs Downgrades Nabors (NBR) to Buy
Tweet
Share
E-mailGet Alerts NBR Hot Sheet
Price: $77.04 +2.58%
Rating Summary:
11 Buy, 17 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Rating Summary:
11 Buy, 17 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Join SI Premium – FREE
Goldman Sachs downgraded Nabors (NYSE: NBR) from Conviction Buy to Buy with a price target of $19.50 (from $22.00). The change follows a Q2 earnings warning issued by Nabors yesterday.
"We are disappointed by the new guidance as we were confident that NBR would meet our forecast of $119mn in EBIT. We were expecting the company's manufacturing and logistics business to report about $6mn in EBIT, but we believe most likely that business returned a loss, which would explain perhaps half of the miss. The remainder of the miss was probably in the pressure pumping business, owing to inclement weather in Canada and the US Rockies," said analyst Waqar Syed.
Goldman cut its 2013/14 EPS estimate to $0.82/$1.37 from $1.04/$1.85. 2013/14 EBITDA was cut 5% & 9%, respectively.
For an analyst ratings summary and ratings history on Nabors click here. For more ratings news on Nabors click here.
Shares of Nabors closed at $16.00 yesterday.
"We are disappointed by the new guidance as we were confident that NBR would meet our forecast of $119mn in EBIT. We were expecting the company's manufacturing and logistics business to report about $6mn in EBIT, but we believe most likely that business returned a loss, which would explain perhaps half of the miss. The remainder of the miss was probably in the pressure pumping business, owing to inclement weather in Canada and the US Rockies," said analyst Waqar Syed.
Goldman cut its 2013/14 EPS estimate to $0.82/$1.37 from $1.04/$1.85. 2013/14 EBITDA was cut 5% & 9%, respectively.
For an analyst ratings summary and ratings history on Nabors click here. For more ratings news on Nabors click here.
Shares of Nabors closed at $16.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cleveland Research Upgrades Dynatrace Inc. (DT) to Buy, 'optimism underlying fundamentals are likely to support upside'
- HSBC Upgrades Topdanmark (TOP:DC) (TPDKY) to Hold
- Stifel Downgrades Shield Therapeutics PLC (STX:LN) to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change, DowngradesRelated Entities
Goldman Sachs Conviction Buy List, Goldman Sachs, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
